Angiotensin Receptor Neprilysin Inhibition?in Heart Failure With Preserved?Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.

Angiotensin Receptor Neprilysin Inhibition?in Heart Failure With Preserved?Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. JACC Heart Fail. 2017 07; 5(7):471-482.

View in: PubMed

subject areas

Aminobutyrates
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Biphenyl Compounds
Double-Blind Method
Drug Combinations
Drug Therapy, Combination
Heart Failure
Humans
Neprilysin
Randomized Controlled Trials as Topic
Tetrazoles
Treatment Outcome
Valsartan

authors with profiles

Michael R. Zile